Delivery Order SPE2DR25D1109-SPE2DR26FFK0M
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,497.32 by the Defense Logistics Agency on December 11, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 5, 2026, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,999.36 for Benlysta 400 mg vials, with an ultimate completion date of June 23, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to AmerisourceBergen's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,888.86 in Benlysta 400 mg vials on September 26, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with the Defense Logistics Agency. The product will be delivered to the company's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a $11,648.08 delivery order by the Defense Logistics Agency (DLA) on January 2, 2026, for the supply of Benlysta 400 mg vials, with an ultimate completion date of January 26, 2026. This firm fixed-price contract involves no set-aside designation, indicating it was competitively awarded. The place of performance is listed as the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 16, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Benlysta 400 mg vials, with a contract ceiling value of $15,777.72. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025. The contract was awarded on a competitive basis without any set-aside designation. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on January 5, 2026, with an ultimate completion date of January 27, 2026. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,497.32 for Benlysta 200 mg/ml auto-injector on November 18, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $10,518.48 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single procurement action under the company's broader pharmaceutical supply agreement with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFK0MDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,912.02 by the Defense Logistics Agency on January 5, 2026, for the supply of Benlysta 400 mg vials. The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of January 27, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The award represents a routine pharmaceutical procurement fulfilling the Defense Logistics Agency's medical supply chain requirements. Benlysta (belimumab) is a monoclonal antibody used for systemic lupus erythematosus treatment and is among the specialized medications AmerisourceBergen provides through its extensive federal contract portfolio. The competitive award to AmerisourceBergen demonstrates the company's established capability to meet federal medical procurement standards. This delivery order supports military healthcare systems and the Defense Health Agency's broader initiatives to ensure availability of specialized pharmaceutical treatments across the armed forces.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/4/26 |